March 12, 2020 / 11:38 AM / 23 days ago

BRIEF-Abbvie Gets EU Approval For Venclyxto Combination Regimen For Chronic Lymphocytic Leukemia Patients

March 12 (Reuters) - Abbvie Inc:

* ABBVIE RECEIVES EUROPEAN COMMISSION APPROVAL OF VENCLYXTO® COMBINATION REGIMEN FOR PATIENTS WITH PREVIOUSLY-UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below